These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15157953)

  • 1. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
    Haack M; Pollmächer T; Mullington JM
    Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
    Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
    Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Jirsa M; Tesar V
    Cas Lek Cesk; 1998 May; 137(11):341-5. PubMed ID: 9727208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.
    Shearer WT; Reuben JM; Mullington JM; Price NJ; Lee BN; Smith EO; Szuba MP; Van Dongen HP; Dinges DF
    J Allergy Clin Immunol; 2001 Jan; 107(1):165-70. PubMed ID: 11150007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of soluble interleukin-2 receptor in healthy individuals.
    Lemmer B; Schwuléra U; Thrun A; Lissner R
    Eur Cytokine Netw; 1992; 3(3):335-6. PubMed ID: 1498263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
    Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
    J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.
    Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD
    Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E; Pietruska Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
    Muc-Wierzgon M; Nowakowska-Zajdel E; Zubelewicz B; Wierzgon J; Kokot T; Klakla K; Szkilnik R; Wiczkowski A
    J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans--a possible explanation for the circadian kinetics of TNR-alpha effects.
    Liebmann PM; Reibnegger G; Lehofer M; Moser M; Pürstner P; Mangge H; Schauenstein K
    Int Immunol; 1998 Sep; 10(9):1393-6. PubMed ID: 9786439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M; Martignoni M; Petropoulou T; Sölder B; Belohradsky BH
    Infection; 1996; 24(4):301-8. PubMed ID: 8875282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
    Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
    Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
    J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion.
    Vgontzas AN; Pejovic S; Zoumakis E; Lin HM; Bixler EO; Basta M; Fang J; Sarrigiannidis A; Chrousos GP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E253-61. PubMed ID: 16940468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.